FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
28/07/2026
Voltar para busca
Dado oficial do USPTO
BIOCELLIC
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
BIOCELLIC
ST13
US500000079414765Classe
1, 3, 5, 17
Pedido
79414765
Registro
8226581
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
29
Atualização mais recente
28/07/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 3, 5, 17
Data de depósito
31/10/2024
Data de registro
28/04/2026
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
28/04/2026
Última transação
28/07/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
DE
Examinador
SWAIN, MICHELE LYNN
Unidade examinadora
M70
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
JeNaCell GmbH
Representantes
Joseph V. Norvell
Classificação técnica
Classes Nice
Classe 1Classe 3Classe 5Classe 17
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Cellulose precursors and cellulose intermediates for cosmeticalpharmaceuticalmedical and veterinary-medical end products; cellulose for use as raw material for wound dressings; cellulose made by bacteria; cellulose for industrial purposes; cellulose gel; nanocellulose; unprocessed cellulose fleececellulose foilcellulose films and cellulose fibres; cellulose fibres suspensions and cellulose gels of nanocellulose; cellulose and nanocellulose productsbiosynthetic cellulose and synthetic cellulose as precursors for veterinarycosmetical productsparticularly for wound dressings; cellulose ingredients for use in the cosmetic and medical industries; cellulose and nanocellulose productsbiosynthetic cellulose and synthetic cellulose as precursors for pharmaceutical products; cellulose-based ingredients for use in manufacturing cosmetics industry and the medical device industry; cellulose-based ingredients as support materialthickening and binding agents for use in manufacturing cosmetics and medical productsparticularly wound dressings and skin care preparations; cellulose for the food industry; cellulose derivatives for use manufacturing; diagnostic preparations and substances for scientific purposes; diagnostic testing materials for scientific use; none of the above-mentioned goods being products to be taken orally; none of the above-mentioned goods being products containing collagen
Classe 3
Cosmetics and cosmetic preparations; cosmetic-based cellulose fleececellulose foilscellulose filmscellulose fibrescellulose fibre suspensions and cellulose gels impregnated with cosmetic active ingredientsparticularly skin care preparations; beauty masks; skin masks; facial masks; body masksskin care preparations; none of the above-mentioned goods being products to be taken orally; none of the above-mentioned goods being products containing collagen.
Classe 5
Medical and veterinary preparationscellulose productsbiosynthetic cellulose and synthetic cellulose for skin treatment; flat cellulosecellulose filmscellulose foilscellulose fleececellulose fibrescellulose fibre suspension and cellulose gels for medicalveterinary and pharmaceutical purposes; pharmaceutical preparations featuring cellulose fleececellulose filmscellulose foilscellulose fibrescellulose fibre suspensions and cellulose gels for use in the treatment of skin; pharmaceutical preparations featuring cellulose fleececellulose filmscellulose foilscellulose fibrescellulose fibre suspension and cellulose gels impregnated with pharmaceutical agents for use in the treatment of skin; pads impregnated with medicated preparation for use in the treatment of skin for medical purposes; cellulose for pharmaceuticalveterinary and medical purposes; pharmaceutical preparations for skin care; absorbent sanitary pads for skin treatment; pantyliners; diapers; sanitary pads; preparations for the treatment of burnsexcept ready-to-use wound dressings; diagnostic preparations for pharmaceuticalmedical and veterinary purposes.
Classe 17
Semi-finished productssynthetic resins for making materials for dressing wounds and surgical dressings; semi-finished productsacrylics made of cellulosecellulose fleececellulose filmscellulose foilscellulose fibrescellulose fibre suspension and cellulose gels for making material for dressings and surgical dressings; semi-finished molded products of cellulose fleececellulose filmscellulose foilscellulose fibrescellulose fibre suspension and cellulose gels for use as semi-finished products for making absorbent sanitary articlespantylinersdiapers and sanitary pads; semi-processed cellulose fleececellulose foilcellulose films and cellulose fibres for use in food and beverages
Publicações
Histórico de despachos e eventos da marca no USPTO.
29 publicações encontradas
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
02/07/2026
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
15/06/2026
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
15/06/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
28/04/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
28/04/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/03/2026
PUBO
PUBLISHED FOR OPPOSITION
10/03/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/03/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
17/02/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
22/01/2026
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
22/01/2026
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
22/01/2026
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
16/12/2025
GNRT
NON-FINAL ACTION E-MAILED
16/12/2025
CNRT
NON-FINAL ACTION WRITTEN
16/12/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
21/11/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
21/11/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
21/11/2025
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
26/09/2025
RFNT
REFUSAL PROCESSED BY IB
05/07/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
13/06/2025
RFRR
REFUSAL PROCESSED BY MPU
13/06/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
29/03/2025
CNRT
NON-FINAL ACTION WRITTEN
28/03/2025
DOCK
ASSIGNED TO EXAMINER
27/03/2025
MAFR
APPLICATION FILING RECEIPT MAILED
16/01/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
16/01/2025
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
16/01/2025
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace BIOCELLIC ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.